These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 77140)

  • 21. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 22. The effectiveness of antiarrhythmic agents on early-cycle premature ventricular complexes.
    Krone RJ; Miller JP; Kleiger RE; Clark KW; Oliver GC
    Circulation; 1981 Mar; 63(3):664-9. PubMed ID: 7006853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole].
    Barnay C; Medvedowsky JL; Clémenty J; Bricaud H; Pellet J; Denis B; Machecourt J; Wolf JE; Dimitrio R; Egre A
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):909-17. PubMed ID: 6194768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oxprenolol in the treatment and prevention of cardiac arrhythmias].
    Martinoli E; Medugno G; Crepaldi L; Scardi S; Camerini F
    Minerva Med; 1975 Oct; 66(68):3566-73. PubMed ID: 52854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and electrophysiological effects of intravenous quinidine in man.
    Hirschfeld DS; Ueda CT; Rowland M; Scheinman MM
    Br Heart J; 1977 Mar; 39(3):309-16. PubMed ID: 849392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of antiarrhythmic properties of quinicine versus quinidine (author's transl)].
    Pecquet-Bathellier C; Quevauviller A
    Sem Hop; 1978 Oct 8-15; 54(29-32):953-7. PubMed ID: 216087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous ECG (Holter) recordings in the evaluation of antiarrhythmic drugs.
    Bleifer DJ; Hansmann DR; Bleifer SB; Sheppard JS; Karpman HL
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1585-6. PubMed ID: 4138545
    [No Abstract]   [Full Text] [Related]  

  • 29. Spontaneous variability and detection of repetitive extrasystoles during simulated acute antiarrhythmic testing.
    Hernández-Acosta K; Groning E; Rodríguez-Bereao C; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1985; 27(4):287-92. PubMed ID: 2414060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
    Accettura D; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Mastropasqua F; Caiati C; Rizzon P
    Cardiologia; 1987 Sep; 32(9):999-1003. PubMed ID: 2446764
    [No Abstract]   [Full Text] [Related]  

  • 32. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacokinetics and efficacy of delayed-action hydroquinidine in patients with ventricular extrasystole].
    Victor J; Turcant A; Tadei A; Allain P
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):163-6. PubMed ID: 2436547
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of cardiac arrhythmias and their prevention with quinidine in patients with acute coronary insufficiency.
    Bloomfield SS; Romhilt DW; Chou TC; Fowler NO
    Circulation; 1973 May; 47(5):967-73. PubMed ID: 4574570
    [No Abstract]   [Full Text] [Related]  

  • 38. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Holter monitoring in patients with focal cerebral ischaemic attacks (author's transl)].
    Tonet JL; Frank R; Ducardonnet A; Fillette F; Fontaine G; Komajda M; Thomas D; Bousser MG; Grosgogeat Y
    Nouv Presse Med; 1981 Jul 11-25; 10(30):2491-4. PubMed ID: 6167934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.